Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
Total | Transactions | Amount |
Buys | 94 | $26,838,536 |
Sells | 661 | $433,338,369 |
Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
03 May 2024 16:18 | TRU | TransUnion | CHAOUKI STEVEN M | President, US Markets | 01 May 2024 | Sale | 1,776 | 73.15 | 129,914 | D |
03 May 2024 16:18 | GTLB | Gitlab Inc | ROBINS BRIAN G | Chief Financial Officer | 01 May 2024 | Sale | 5,871 | 54.33 | 318,971 | D |
03 May 2024 16:18 | GTLB | Gitlab Inc | ROBINS BRIAN G | Chief Financial Officer | 01 May 2024 | Sale | 13,983 | 53.31 | 745,434 | D |
03 May 2024 16:18 | GTLB | Gitlab Inc | ROBINS BRIAN G | Chief Financial Officer | 01 May 2024 | Sale | 10,146 | 52.6 | 533,680 | D |
03 May 2024 16:18 | PCVX | Vaxcyte Inc | PICKERING GRANT | CHIEF EXECUTIVE OFFICER | 01 May 2024 | Sale | 46 | 63.84 | 2,937 | I |
03 May 2024 16:18 | PCVX | Vaxcyte Inc | PICKERING GRANT | CHIEF EXECUTIVE OFFICER | 01 May 2024 | Sale | 582 | 62.066 | 36,122 | I |
03 May 2024 16:18 | PCVX | Vaxcyte Inc | PICKERING GRANT | CHIEF EXECUTIVE OFFICER | 01 May 2024 | Sale | 72 | 63.87 | 4,599 | I |
03 May 2024 16:18 | PCVX | Vaxcyte Inc | PICKERING GRANT | CHIEF EXECUTIVE OFFICER | 01 May 2024 | Sale | 680 | 61.282 | 41,672 | I |
03 May 2024 16:18 | PCVX | Vaxcyte Inc | PICKERING GRANT | CHIEF EXECUTIVE OFFICER | 01 May 2024 | Sale | 508 | 62.006 | 31,499 | I |
03 May 2024 16:18 | PCVX | Vaxcyte Inc | PICKERING GRANT | CHIEF EXECUTIVE OFFICER | 01 May 2024 | Sale | 728 | 61.251 | 44,591 | I |
03 May 2024 16:19 | TBPH | Theravance Biopharma Inc | SAMAHA ELI | 10% | 01 May 2024 | Purchase | 499,324 | 8.75 | 4,369,085 | I |
03 May 2024 16:19 | TBPH | Theravance Biopharma Inc | SAMAHA ELI | 10% | 01 May 2024 | Purchase | 999,800 | 8.75 | 8,748,250 | I |
03 May 2024 16:19 | PCVX | Vaxcyte Inc | WASSIL JIM | CHIEF OPERATING OFFICER | 01 May 2024 | Sale | 185 | 63.646 | 11,775 | D |
03 May 2024 16:19 | PCVX | Vaxcyte Inc | WASSIL JIM | CHIEF OPERATING OFFICER | 01 May 2024 | Sale | 1,753 | 61.227 | 107,331 | D |
03 May 2024 16:19 | PCVX | Vaxcyte Inc | WASSIL JIM | CHIEF OPERATING OFFICER | 01 May 2024 | Sale | 1,062 | 61.993 | 65,837 | D |
03 May 2024 16:20 | TOST | Toast Inc | VASSIL JONATHAN | Chief Revenue Officer | 02 May 2024 | Sale | 1,459 | 22.96 | 33,499 | D |
03 May 2024 16:20 | PCVX | Vaxcyte Inc | EYDELMAN MIKHAIL | SVP, GEN COUNSEL & CORP SEC | 01 May 2024 | Sale | 144 | 63.903 | 9,202 | D |
03 May 2024 16:20 | PCVX | Vaxcyte Inc | EYDELMAN MIKHAIL | SVP, GEN COUNSEL & CORP SEC | 01 May 2024 | Sale | 559 | 61.948 | 34,629 | D |
03 May 2024 16:20 | PCVX | Vaxcyte Inc | EYDELMAN MIKHAIL | SVP, GEN COUNSEL & CORP SEC | 01 May 2024 | Sale | 964 | 61.297 | 59,090 | D |
03 May 2024 16:21 | TOST | Toast Inc | NARANG AMAN | CEO | 02 May 2024 | Sale | 1,064 | 22.96 | 24,429 | D |
03 May 2024 16:21 | VRSK | Verisk Analytics Inc | MANN ELIZABETH | Chief Financial Officer | 01 May 2024 | Sale | 200 | 230 | 46,000 | D |
03 May 2024 16:21 | COF | CAPITAL ONE FINANCIAL CORP | WEST KARA | Chief Enterprise Risk Officer | 02 May 2024 | Sale | 1,212 | 141.87 | 171,946 | D |
03 May 2024 16:21 | TOST | Toast Inc | MATLOCK JAMES MICHAEL | Principal Accounting Officer | 02 May 2024 | Sale | 6,098 | 22.96 | 140,010 | D |
03 May 2024 16:21 | CRM | Salesforce Inc | BENIOFF MARC | Chair and CEO | 02 May 2024 | Sale | 7,674 | 271.7755 | 2,085,605 | D |
03 May 2024 16:21 | CRM | Salesforce Inc | BENIOFF MARC | Chair and CEO | 02 May 2024 | Sale | 600 | 272.485 | 163,491 | D |
03 May 2024 16:21 | CRM | Salesforce Inc | BENIOFF MARC | Chair and CEO | 02 May 2024 | Sale | 3,716 | 270.7495 | 1,006,105 | D |
03 May 2024 16:21 | CRM | Salesforce Inc | BENIOFF MARC | Chair and CEO | 02 May 2024 | Sale | 2,044 | 269.8538 | 551,581 | D |
03 May 2024 16:21 | CRM | Salesforce Inc | BENIOFF MARC | Chair and CEO | 02 May 2024 | Sale | 966 | 268.9901 | 259,844 | D |
03 May 2024 16:22 | NOTE | FiscalNote Holdings Inc | HWANG TIM | Chairman, CEO and Director, 10% | 01 May 2024 | Sale | 30,168 | 1.3288 | 40,087 | I |
03 May 2024 16:22 | ARQT | Arcutis Biotherapeutics Inc | BURNETT PATRICK | See Remarks | 02 May 2024 | Sale | 9,555 | 8.7378 | 83,490 | D |
03 May 2024 16:22 | SMCI | Super Micro Computer Inc | FAIRFAX DANIEL W | Director | 01 May 2024 | Sale | 300 | 777.36 | 233,208 | D |
03 May 2024 16:22 | TOST | Toast Inc | GOMEZ ELENA | Chief Financial Officer | 02 May 2024 | Sale | 2,041 | 22.96 | 46,861 | D |
03 May 2024 16:22 | ARQT | Arcutis Biotherapeutics Inc | MATSUDA MASARU | See Remark | 02 May 2024 | Sale | 5,016 | 8.7378 | 43,829 | D |
03 May 2024 16:22 | ARQT | Arcutis Biotherapeutics Inc | WATANABE TODD FRANKLIN | See Remarks | 02 May 2024 | Sale | 13,783 | 8.7378 | 120,433 | D |
03 May 2024 16:23 | TOST | Toast Inc | FREDETTE STEPHEN | President | 02 May 2024 | Sale | 1,064 | 22.96 | 24,429 | D |
03 May 2024 16:23 | VRSK | Verisk Analytics Inc | LISS SAMUEL G | Director | 03 May 2024 | Sale | 926 | 235.87 | 218,416 | D |
03 May 2024 16:23 | VRSK | Verisk Analytics Inc | LISS SAMUEL G | Director | 03 May 2024 | Sale | 10,016 | 235.41 | 2,357,867 | D |
03 May 2024 16:23 | VRSK | Verisk Analytics Inc | LISS SAMUEL G | Director | 03 May 2024 | Sale | 3,113 | 234.34 | 729,500 | D |
03 May 2024 16:24 | TOST | Toast Inc | ELWORTHY BRIAN R | General Counsel | 02 May 2024 | Sale | 651 | 22.96 | 14,947 | D |
03 May 2024 16:24 | BJ | BJ's Wholesale Club Holdings Inc | EDDY ROBERT W. | President & CEO | 01 May 2024 | Sale | 4,483 | 75.36 | 337,839 | D |
03 May 2024 16:24 | BJ | BJ's Wholesale Club Holdings Inc | EDDY ROBERT W. | President & CEO | 01 May 2024 | Sale | 6,517 | 74.79 | 487,406 | D |
03 May 2024 16:24 | CVLT | COMMVAULT SYSTEMS INC | BEJAR MARTHA HELENA | Director | 01 May 2024 | Sale | 6,000 | 103.23 | 619,380 | D |
03 May 2024 16:24 | STOK | Stoke Therapeutics Inc | TICHO BARRY | CHIEF MEDICAL OFFICER | 01 May 2024 | Sale | 10,000 | 11.3653 | 113,653 | D |
03 May 2024 16:29 | ARQT | Arcutis Biotherapeutics Inc | MOORE MATTHEW RICHARD | SVP and Chief Business Officer | 02 May 2024 | Sale | 4,681 | 8.7378 | 40,902 | D |
03 May 2024 16:30 | GD | GENERAL DYNAMICS CORP | GILLILAND MARGUERITE AMY | Senior Vice President | 02 May 2024 | Sale | 5,116 | 286.04 | 1,463,381 | D |
03 May 2024 16:30 | GD | GENERAL DYNAMICS CORP | GILLILAND MARGUERITE AMY | Senior Vice President | 01 May 2024 | Sale | 3,986 | 287.275 | 1,145,078 | D |
03 May 2024 16:30 | PANW | Palo Alto Networks Inc | ZUK NIR | EVP, Chief Technology Officer | 01 May 2024 | Sale | 1,797 | 292.895 | 526,332 | D |
03 May 2024 16:30 | PANW | Palo Alto Networks Inc | ZUK NIR | EVP, Chief Technology Officer | 01 May 2024 | Sale | 1,850 | 291.984 | 540,170 | D |
03 May 2024 16:30 | PANW | Palo Alto Networks Inc | ZUK NIR | EVP, Chief Technology Officer | 01 May 2024 | Sale | 1,300 | 290.921 | 378,197 | D |
03 May 2024 16:30 | PANW | Palo Alto Networks Inc | ZUK NIR | EVP, Chief Technology Officer | 01 May 2024 | Sale | 2,555 | 289.616 | 739,969 | D |
03 May 2024 16:30 | PANW | Palo Alto Networks Inc | ZUK NIR | EVP, Chief Technology Officer | 01 May 2024 | Sale | 6,900 | 288.994 | 1,994,059 | D |
03 May 2024 16:30 | PANW | Palo Alto Networks Inc | ZUK NIR | EVP, Chief Technology Officer | 01 May 2024 | Sale | 11,098 | 287.933 | 3,195,480 | D |
03 May 2024 16:30 | PANW | Palo Alto Networks Inc | ZUK NIR | EVP, Chief Technology Officer | 01 May 2024 | Sale | 3,700 | 286.768 | 1,061,042 | D |
03 May 2024 16:30 | PANW | Palo Alto Networks Inc | ZUK NIR | EVP, Chief Technology Officer | 01 May 2024 | Sale | 5,900 | 285.677 | 1,685,494 | D |
03 May 2024 16:30 | PANW | Palo Alto Networks Inc | ZUK NIR | EVP, Chief Technology Officer | 01 May 2024 | Sale | 900 | 284.518 | 256,066 | D |
03 May 2024 16:30 | TMDX | TransMedics Group Inc | KHAYAL TAMER I | Chief Commercial Officer | 01 May 2024 | Sale | 7,388 | 120.01 | 886,634 | I |
03 May 2024 16:30 | TMDX | TransMedics Group Inc | KHAYAL TAMER I | Chief Commercial Officer | 01 May 2024 | Sale | 500 | 111.5 | 55,750 | I |
03 May 2024 16:30 | TMDX | TransMedics Group Inc | KHAYAL TAMER I | Chief Commercial Officer | 01 May 2024 | Sale | 6,888 | 110.06 | 758,093 | I |
03 May 2024 16:30 | TMDX | TransMedics Group Inc | KHAYAL TAMER I | Chief Commercial Officer | 01 May 2024 | Sale | 100 | 123.66 | 12,366 | D |
03 May 2024 16:30 | TMDX | TransMedics Group Inc | KHAYAL TAMER I | Chief Commercial Officer | 01 May 2024 | Sale | 17 | 122.51 | 2,083 | D |
03 May 2024 16:30 | TMDX | TransMedics Group Inc | KHAYAL TAMER I | Chief Commercial Officer | 01 May 2024 | Sale | 532 | 121.74 | 64,766 | D |
03 May 2024 16:30 | TMDX | TransMedics Group Inc | KHAYAL TAMER I | Chief Commercial Officer | 01 May 2024 | Sale | 512 | 120.86 | 61,880 | D |
03 May 2024 16:30 | TMDX | TransMedics Group Inc | KHAYAL TAMER I | Chief Commercial Officer | 01 May 2024 | Sale | 1,799 | 119.85 | 215,610 | D |
03 May 2024 16:30 | TMDX | TransMedics Group Inc | KHAYAL TAMER I | Chief Commercial Officer | 01 May 2024 | Sale | 1,259 | 118.93 | 149,733 | D |
03 May 2024 16:30 | TMDX | TransMedics Group Inc | KHAYAL TAMER I | Chief Commercial Officer | 01 May 2024 | Sale | 738 | 117.96 | 87,054 | D |
03 May 2024 16:30 | TMDX | TransMedics Group Inc | KHAYAL TAMER I | Chief Commercial Officer | 01 May 2024 | Sale | 100 | 113.16 | 11,316 | D |
03 May 2024 16:30 | TMDX | TransMedics Group Inc | KHAYAL TAMER I | Chief Commercial Officer | 01 May 2024 | Sale | 326 | 116.8 | 38,077 | D |
03 May 2024 16:30 | TMDX | TransMedics Group Inc | KHAYAL TAMER I | Chief Commercial Officer | 01 May 2024 | Sale | 15,892 | 109.83 | 1,745,418 | D |
03 May 2024 16:30 | TMDX | TransMedics Group Inc | KHAYAL TAMER I | Chief Commercial Officer | 01 May 2024 | Sale | 3,027 | 109.28 | 330,791 | D |
03 May 2024 16:30 | TMDX | TransMedics Group Inc | KHAYAL TAMER I | Chief Commercial Officer | 01 May 2024 | Sale | 3,477 | 107.84 | 374,960 | D |
03 May 2024 16:30 | TMDX | TransMedics Group Inc | KHAYAL TAMER I | Chief Commercial Officer | 01 May 2024 | Sale | 12,250 | 107 | 1,310,750 | D |
03 May 2024 16:30 | TMDX | TransMedics Group Inc | KHAYAL TAMER I | Chief Commercial Officer | 01 May 2024 | Sale | 23,231 | 105.96 | 2,461,557 | D |
03 May 2024 16:30 | TPET | Trio Petroleum Corp | PERNICE THOMAS J | Director | 01 May 2024 | Sale | 10,000 | 0.3302 | 3,302 | D |
03 May 2024 16:30 | TMDX | TransMedics Group Inc | HASSANEIN WALEED H | President & CEO | 02 May 2024 | Sale | 82 | 122.67 | 10,059 | D |
03 May 2024 16:30 | TMDX | TransMedics Group Inc | HASSANEIN WALEED H | President & CEO | 02 May 2024 | Sale | 6,222 | 122.16 | 760,080 | D |
03 May 2024 16:30 | TMDX | TransMedics Group Inc | HASSANEIN WALEED H | President & CEO | 02 May 2024 | Sale | 6,140 | 120.64 | 740,730 | D |
03 May 2024 16:30 | TMDX | TransMedics Group Inc | HASSANEIN WALEED H | President & CEO | 01 May 2024 | Sale | 22,500 | 120.25 | 2,705,625 | D |
03 May 2024 16:30 | TMDX | TransMedics Group Inc | HASSANEIN WALEED H | President & CEO | 01 May 2024 | Sale | 23,500 | 114.17 | 2,682,995 | D |
03 May 2024 16:30 | TMDX | TransMedics Group Inc | HASSANEIN WALEED H | President & CEO | 01 May 2024 | Sale | 6,800 | 110 | 748,000 | D |
03 May 2024 16:30 | TMDX | TransMedics Group Inc | HASSANEIN WALEED H | President & CEO | 01 May 2024 | Sale | 424 | 107.57 | 45,610 | D |
03 May 2024 16:30 | TMDX | TransMedics Group Inc | HASSANEIN WALEED H | President & CEO | 01 May 2024 | Sale | 91 | 106.51 | 9,692 | D |
03 May 2024 16:30 | TMDX | TransMedics Group Inc | HASSANEIN WALEED H | President & CEO | 01 May 2024 | Sale | 2,685 | 105.56 | 283,429 | D |
03 May 2024 16:30 | IHT | INNSUITES HOSPITALITY TRUST | WIRTH JAMES F | President & CEO, 10% | 01 May 2024 | Purchase | 200 | 288.39 | 57,678 | D |
03 May 2024 16:31 | BKNG | Booking Holdings Inc | VOJVODICH RADAKOVICH LYNN | Director | 01 May 2024 | Sale | 22 | 3,437.25 | 75,620 | I |
03 May 2024 16:31 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | 02 May 2024 | Sale | 273 | 259.8 | 70,925 | D |
03 May 2024 16:31 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | 02 May 2024 | Sale | 1,373 | 259.1182 | 355,769 | D |
03 May 2024 16:31 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | 02 May 2024 | Sale | 1,203 | 258.1091 | 310,505 | D |
03 May 2024 16:31 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | 02 May 2024 | Sale | 296 | 256.1733 | 75,827 | D |
03 May 2024 16:31 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | 02 May 2024 | Sale | 264 | 255.6178 | 67,483 | D |
03 May 2024 16:31 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | 02 May 2024 | Sale | 191 | 254.4474 | 48,599 | D |
03 May 2024 16:31 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | 01 May 2024 | Sale | 26 | 257.5527 | 6,696 | D |
03 May 2024 16:31 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | 01 May 2024 | Sale | 95 | 256.13 | 24,332 | D |
03 May 2024 16:31 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | 01 May 2024 | Sale | 558 | 254.9851 | 142,282 | D |
03 May 2024 16:31 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | 01 May 2024 | Sale | 610 | 254.0661 | 154,980 | D |
03 May 2024 16:31 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | 01 May 2024 | Sale | 501 | 251.544 | 126,024 | D |
03 May 2024 16:31 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | 01 May 2024 | Sale | 307 | 252.9062 | 77,642 | D |
03 May 2024 16:31 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | 01 May 2024 | Sale | 208 | 250.3317 | 52,069 | D |
03 May 2024 16:31 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | 01 May 2024 | Sale | 291 | 248.775 | 72,394 | D |
03 May 2024 16:31 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | 01 May 2024 | Sale | 231 | 247.3562 | 57,139 | D |
03 May 2024 16:31 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | CHAIRPERSON & CEO | 01 May 2024 | Sale | 186 | 245.2621 | 45,619 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)